Time Trends in Gastroparesis Treatment
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Introduction While delayed emptying is the defining criterion for gastroparesis, prokinetics often only have a limited impact on symptoms and have been associated with potentially serious adverse effects. The goal of this study was to determine how this information and regulatory changes affected gastroparesis management.Methods The electronic medical records of patients seen between 2003 and 2012 in the outpatient clinic of a large tertiary center were retrieved based on the billing diagnosis of gastroparesis. Demographic, clinical, and survival data were abstracted.Results A total of 709 patients were identified, with diabetes (21.2 %) and prior surgery (9.8 %) being the most common identifiable causes. The majority of patients (56 %) had idiopathic gastroparesis. The cohort was female predominant (79.5 %) with an average age of 45.4 ± 0.6 years. At the index encounter, 61.8 % received prokinetics. About one-third (37.7 %) used antiemetics at least intermittently. Between 2003 and 2012, prokinetic use dropped from 81 to 43 %, while the use of antiemetics increased from 14 to 41 %. Similarly, there was a significant increase in prescribed opioids and antidepressants. During the period of the study, 44 patients (6.2 %) died. Increasing age, a higher comorbidity burden, anxiety, and medication use were associated with higher mortality risks.Conclusion This large outpatient cohort suggests that treatment trends move away from prokinetics and focus on symptom-oriented therapy and/or confounding mood disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with gastroparesis, in tertiary centers or the community, survival was significantly lower than in the overall population (4, 28).”
From Diabetic Gastroparesis. (2019) · cites this paper as [28]
In the citing paper
“Likewise, in a tertiary referral cohort, survival was better in postinfectious and idiopathic gastroparesis than in DM and postsurgical gastroparesis (28).”
From Diabetic Gastroparesis. (2019) · cites this paper as [28]
In the citing paper
“In case series, estimated mortality rates in patients with gastroparesis range from 38% at 4 years to 34% at 25 years (28–33).”
From Diabetic Gastroparesis. (2019) · cites this paper as [28]
Citations
Cites
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90318-p · Cited by 5,737
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198 · cited 6×
“In the USA, only metoclopramide and erythromycin are available as approved medications with prokinetic effects on gastric emptying.”
BackgroundInfluentialAssociation Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Bohnert, A. S. B. (2011) · JAMA · doi:10.1001/jama.2011.370 · Cited by 1,509
Opioid Epidemic in the United States
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es9 · Cited by 1,180
Clinical Guideline: Management of Gastroparesis
Camilleri, M., Parkman, H. P., Shafi, M. A., Abell, T. L., & Gerson, L. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.373 · Cited by 1,149
Whitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116 · cited 1×
“As is true for other functional illnesses, gastroparesis is commonly associated with other functional and affective spectrum disorders, which may also contribute to the high number of persons using antidepressants and anxiolytics [47, 51].”
BackgroundLichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Price, S., Langholff, W., Londhe, A., & Sandborn, W. J. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.218 · Cited by 791
Soykan, I., Sivri, B., Sarosiek, I., Kiernan, B., & Mccallum, R. W. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026665728213 · Cited by 575 · cited 3×
“Overall, key demographic and clinical data are consistent with several prior reports from different areas of the country [13, 18, 22, 52].”
BackgroundResultJung, H., Choung, R. S., Locke, G. R., Schleck, C. D., Zinsmeister, A. R., Szarka, L. A., Mullan, B., & Talley, N. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.047 · Cited by 571
Cited by
Bharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Systematic review and meta-analysis: Gastric electrical stimulation for gastroparesis
Levinthal, D. J., & Bielefeldt, K. (2016) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.03.004 · Cited by 96
“This caution is particularly notable for gastroparesis, which significantly impairs quality of life, but has a generally low mortality that is largely related to complications of comorbidities (Dudekula et al., 2014), rather than to the disease itself.”
BackgroundDiabetic gastroparesis alters the biomagnetic signature of the gastric slow wave
Bradshaw, L. A., Cheng, L. K., Chung, E., Obioha, C., Erickson, J. C., Gorman, B. L., Somarajan, S., & Richards, W. O. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12780 · Cited by 48
Empirically supported use of psychiatric medications in adolescents and adults with IBD
Thorkelson, G., Bielefeldt, K., & Szigethy, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000734 · Cited by 39
“rising use of these agents in patients with gastrointestinal disorders, which is consistent with the overall trend mentioned.(29) The apparent discrepancy in the stable prevalence of depression and”
ResultSelf-citationZhang, Y., Lu, T., Dong, Y., Chen, Y., & Chen, J. D. Z. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14163 · Cited by 22
Metadata
- Authors
- Dudekula, A., Rahim, S., & Bielefeldt, K.
- Affiliations
- University of Pittsburgh Medical Center (US)
- Corresponding author
- Bielefeldt, Klaus
- Venue
- Digestive Diseases and Sciences
- Published
- 2014-09-26
- Volume
- 59
- Issue
- 11
- Pages
- 2656-2665
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2058952696
- Cited by
- 21
- References
- 53
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2017: 2 · 2016: 4 · 2015: 2
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- gastroparesis, prokinetic agents, antiemetics, opioid use, antidepressant use, treatment trends, mortality risk factors, idiopathic gastroparesis, diabetes mellitus, delayed gastric emptying, mood disorders, adverse drug reactions
- MeSH terms
- Female, Gastrointestinal Agents, Humans, Male, Middle Aged, Retrospective Studies, Cohort Studies, Gastroparesis, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time Trends in Gastroparesis Treatment. https://app.cochat.ai/papers/10.1007/s10620-014-3369-y
- The paper
- Dudekula, A., Rahim, S., & Bielefeldt, K. (2014). Time Trends in Gastroparesis Treatment. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-014-3369-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.